{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:53:48Z","timestamp":1769075628862,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Intensiva"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.medin.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T14:46:04Z","timestamp":1407249964000},"page":"222-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Grado de adherencia al tratamiento antiv\u00edrico recomendado durante la pandemia y periodo pospand\u00e9mico de gripe A (H1N1)pdm09 en 148 unidades de cuidados intensivos espa\u00f1olas"],"prefix":"10.1016","volume":"39","author":[{"given":"L.","family":"Canadell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Mart\u00edn-Loeches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Trefler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Yebenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Almirall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Olona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Blanquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medin.2014.06.001_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.medin.2009.12.005","article-title":"[Pandemic influenza A in the ICU: Experience in Spain and Latin America. GETGAG\/SEMICYUC\/(Spanish Working Group on Severe Pandemic Influenza A\/SEMICYUC)","volume":"34","author":"Rodr\u00edguez","year":"2010","journal-title":"Med Intensiva"},{"key":"10.1016\/j.medin.2014.06.001_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.medin.2011.03.001","article-title":"First influenza season after the 2009 pandemic influenza: Report of the first 300 ICU admission in Spain","volume":"35","author":"Rodriguez","year":"2011","journal-title":"Med Intensiva"},{"key":"10.1016\/j.medin.2014.06.001_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.medin.2011.11.020","volume":"36","author":"Rodr\u00edguez","year":"2012","journal-title":"Med Intensiva"},{"key":"10.1016\/j.medin.2014.06.001_bib0020","unstructured":"Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. WHO [consultado 7 Abr 2014]. Disponible en: http:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/clinical_management_h1n1.pdf?ua=1"},{"key":"10.1016\/j.medin.2014.06.001_bib0025","unstructured":"ECDC interim guidance on public health use of influenza antivirals during influenza pandemics (August 2009). ECDC [consultado 7 Abr 2014]. Disponible en: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/0907_GUI_Public_Health_use_of_Influenza_Antivirals_during_Influenza_Pandemic.pdf"},{"key":"10.1016\/j.medin.2014.06.001_bib0030","unstructured":"Gu\u00eda del manejo cl\u00ednico de la neumon\u00eda adquirida en el comunidad en el adulto durante la pandemia por el virus influenza A (H1N1) 2009. Ministerio de Sanidad y Pol\u00edtica Social [consultado 23 Mar 2014]. Disponible en: http:\/\/www.msc.es\/profesionales\/saludPublica\/gripeA\/guiasProtocolosInf\/pdf\/neumonia.pdf"},{"key":"10.1016\/j.medin.2014.06.001_bib0035","unstructured":"Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. CDC [consultado 7 Abr 2014]. Disponible en: http:\/\/www.cdc.gov\/h1n1flu\/recommendations.htm"},{"key":"10.1016\/j.medin.2014.06.001_bib0040","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.00167-09","article-title":"Prediciton of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in-vitro hollow-fiber infection model system","volume":"53","author":"McSharry","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medin.2014.06.001_bib0045","unstructured":"Diagn\u00f3stico y tratamiento de los pacientes adultos con insuficiencia respiratoria aguda grave por el nuevo virus de la gripe A (H1N1)v. SEMYCIUC [consultado 15 Mar 2014]. Disponible en: http:\/\/www.semicyuc.org\/sites\/default\/files\/protocolo_manejo_20091015.pdf"},{"key":"10.1016\/j.medin.2014.06.001_bib0050","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/jac\/dkr366","article-title":"Empirical management of community-acquired pneumonia: Impact of concurrent A\/H1N1 influenza pandemic on guideline implementation","volume":"66","author":"Cortoos","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medin.2014.06.001_bib0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1503\/cmaj.091884","article-title":"Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection","volume":"182","author":"Zarychanski","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.medin.2014.06.001_bib0060","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinternmed.2009.259","article-title":"Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: Playing by the rules","volume":"169","author":"McCabe","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medin.2014.06.001_bib0065","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medin.2014.06.001_bib0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1378\/chest.10-1396","article-title":"Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus","volume":"139","author":"Mart\u00edn-Loeches","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.medin.2014.06.001_bib0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1378\/chest.10-1160","article-title":"Impact of obesity in patients infected with new influenza A (H1N1)","volume":"139","author":"D\u00edaz","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.medin.2014.06.001_bib0080","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.medin.2014.06.001_bib0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/cc2955","article-title":"Statistic review 12: Survival analysis","volume":"8","author":"Bewick","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.medin.2014.06.001_bib0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J Roy Statist Soc B"},{"key":"10.1016\/j.medin.2014.06.001_bib0095","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/adc.2010.183806","article-title":"Prescribing in a pandemic: Best use of oseltamivir in paediatric intensive care","volume":"96","author":"Seale","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.medin.2014.06.001_bib0100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3201\/eid1803.111351","article-title":"Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands","volume":"18","author":"Fietj\u00e9","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.medin.2014.06.001_bib0105","doi-asserted-by":"crossref","first-page":"S362","DOI":"10.2105\/AJPH.2009.171462","article-title":"Changes in prescribing of antiviral medications for influenza associated with new treatment guidelines","volume":"99","author":"Hersh","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.medin.2014.06.001_bib0110","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/jac\/dkq511","article-title":"Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A","volume":"66","author":"Rodr\u00edguez","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medin.2014.06.001_bib0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.medin.2014.06.001_bib0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.amjmed.2004.06.028","article-title":"effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia","volume":"117","author":"Mortensen","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.medin.2014.06.001_bib0125","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1183\/09031936.00092607","article-title":"Can CAP guideline adherence improve patients outcome in internal medicine departments?","volume":"32","author":"Blasi","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.medin.2014.06.001_bib0130","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/498119","article-title":"Antibiotic prescription for community-acquired pneumonia in the intensive care unit: Impact of adherence to Infectious Diseases Society of America guidelines on survival","volume":"41","author":"Bod\u00ed","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medin.2014.06.001_bib0135","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1136\/bmj.b5106","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults: Systematic review and meta-analysis","volume":"339","author":"Jefferson","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.medin.2014.06.001_bib0140","first-page":"355","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults: A Cochrane review 2009","volume":"14","author":"Jefferson","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.medin.2014.06.001_bib0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijantimicag.2010.01.006","article-title":"Treatment options for 2009 H1N1 influenza: Evaluation of the published evidence","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medin.2014.06.001_bib0150","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April\u2013June 2009","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medin.2014.06.001_bib0155","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2009.1536","article-title":"Critically ill patients with 2009 influenza A(H1N1) in Mexico","volume":"302","author":"Dom\u00ednguez-Cherit","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.medin.2014.06.001_bib0160","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/jac\/dkr089","article-title":"Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): Retrospective cohort study","volume":"66","author":"Hiba","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medin.2014.06.001_bib0165","doi-asserted-by":"crossref","first-page":"e21838","DOI":"10.1371\/journal.pone.0021838","article-title":"Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: A retrospective study in Mexico","volume":"6","author":"Higuera Iglesias","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.medin.2014.06.001_bib0170","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/cr.2009.111","article-title":"Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A\/H1N1)?","volume":"19","author":"Yu","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.medin.2014.06.001_bib0175","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children [review]","volume":"18","author":"Jefferson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medin.2014.06.001_bib0180","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra1208802","article-title":"Pandemic preparedness and response \u2013 Lesson from the H1N1 influenza of 2009","volume":"370","author":"Fineberg","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Medicina Intensiva"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210569114001430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210569114001430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T22:36:48Z","timestamp":1717195008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210569114001430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0210569114001430"],"URL":"https:\/\/doi.org\/10.1016\/j.medin.2014.06.001","relation":{},"ISSN":["0210-5691"],"issn-type":[{"value":"0210-5691","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Grado de adherencia al tratamiento antiv\u00edrico recomendado durante la pandemia y periodo pospand\u00e9mico de gripe A (H1N1)pdm09 en 148 unidades de cuidados intensivos espa\u00f1olas","name":"articletitle","label":"Article Title"},{"value":"Medicina Intensiva","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medin.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. and SEMICYUC. All rights reserved.","name":"copyright","label":"Copyright"}]}}